Sun Pharmaceutical Industries Approaches 52-Week Low Amid Broader Sector Trends
Sun Pharmaceutical Industries is trading near its 52-week low, reflecting a modest increase today. The stock is below key moving averages, indicating a downward trend. With a market capitalization of Rs 3,81,662.21 crore and a P/E ratio of 33.19, it has seen an 8.37% decline over the past year.
Sun Pharmaceutical Industries, a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, trading close to its 52-week low, just 2% away from Rs 1555. The stock's performance aligns with the sector, reflecting a modest increase of 0.25% for the day, compared to a slight rise of 0.02% in the Sensex.Despite today's uptick, Sun Pharma's trading is currently below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in the short to medium term. The company's market capitalization stands at Rs 3,81,662.21 crore, categorizing it as a large-cap stock. With a price-to-earnings (P/E) ratio of 33.19, it remains competitive against the industry average of 34.40.
Over the past year, Sun Pharmaceutical Industries has experienced a decline of 8.37%, contrasting with the Sensex's modest gain of 0.21%. Year-to-date, the stock has dropped by 15.59%, while its performance over three years shows a significant increase of 72.90%, outperforming the Sensex's 34.62% growth during the same period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
